Cargando…

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy

BACKGROUND: IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide. Tonsillectomy plus steroid pulse therapy has been able to induce clinical remission in early-stage IgAN. However, its possible effect on systemic and local cytokines and tubular markers has not been f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maruyama, Shuntaro, Gohda, Tomohito, Suzuki, Yusuke, Suzuki, Hitoshi, Sonoda, Yuji, Ichikawa, Saki, Li, Zi, Murakoshi, Maki, Horikoshi, Satoshi, Tomino, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142263/ https://www.ncbi.nlm.nih.gov/pubmed/27957418 http://dx.doi.org/10.1016/j.krcp.2016.09.002

Ejemplares similares

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
por: Nakata, Junichiro, et al.
Publicado: (2014)

Role of Mindin in Diabetic Nephropathy
por: Murakoshi, Maki, et al.
Publicado: (2011)

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
por: Sonoda, Yuji, et al.
Publicado: (2015)

Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis
por: Gohda, Tomohito, et al.
Publicado: (2017)

TWEAK/Fn14 system and crescent formation in IgA nephropathy
por: Sasaki, Yohei, et al.
Publicado: (2015)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

Differential organ-specific inflammatory response to progranulin in high-fat diet-fed mice
por: Murakoshi, Maki, et al.
Publicado: (2021)

Nationwide survey on current treatments for IgA nephropathy in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2013)

Different Pathological Roles of Toll-Like Receptor 9 on Mucosal B Cells and Dendritic Cells in Murine IgA Nephropathy
por: Kajiyama, Tadahiro, et al.
Publicado: (2011)

Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice
por: Ichikawa, Saki, et al.
Publicado: (2020)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
por: Furukawa, Masako, et al.
Publicado: (2013)

Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease
por: Murakoshi, Maki, et al.
Publicado: (2020)

Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy
por: Satake, Kenji, et al.
Publicado: (2014)

Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria
por: Komatsu, Hiroyuki, et al.
Publicado: (2015)

The sodium–glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice
por: Li, Zi, et al.
Publicado: (2020)

Pathological Role of Tonsillar B Cells in IgA Nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2011)

Diagnosis and treatment of patients with IgA nephropathy in Japan
por: Tomino, Yasuhiko
Publicado: (2016)

Effect of Exercise on Kidney Function, Oxidative Stress, and Inflammation in Type 2 Diabetic KK-A(y) Mice
por: Ishikawa, Yuji, et al.
Publicado: (2012)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy
por: Kawamura, Tetsuya, et al.
Publicado: (2014)

The Kinetics of Glomerular Deposition of Nephritogenic IgA
por: Yamaji, Kenji, et al.
Publicado: (2014)

Dietary Zinc Is a Key Environmental Modifier in the Progression of IgA Nephropathy
por: Maiguma, Masayuki, et al.
Publicado: (2014)

Progranulin and Its Receptor Predict Kidney Function Decline in Patients With Type 2 Diabetes
por: Murakoshi, Maki, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter-2 Inhibitors—Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials
por: Gohda, Tomohito, et al.
Publicado: (2022)

Associations of corticosteroid therapy and tonsillectomy with kidney survival in a multicenter prospective study for IgA nephropathy
por: Kawamura, Tetsuya, et al.
Publicado: (2023)

Estimated glomerular filtration rate and daily amount of urinary protein predict the clinical remission rate of tonsillectomy plus steroid pulse therapy for IgA nephropathy
por: Suzuki, Keisuke, et al.
Publicado: (2013)

Tonsillectomy Monotherapy for IgA Nephropathy: A Case Series
por: Marumoto, Hirokazu, et al.
Publicado: (2020)

A Case of Arteriovenous Fistula after Renal Biopsy in an IgA Nephropathy Patient with Macroscopic Hematuria
por: Horikoshi, Satoshi, et al.
Publicado: (2013)

Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy
por: Kim, Yang Gyun, et al.
Publicado: (2015)

Circulating kidney injury molecule‐1 as a biomarker of renal parameters in diabetic kidney disease
por: Gohda, Tomohito, et al.
Publicado: (2019)

Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy
por: Seki, Takuto, et al.
Publicado: (2014)

Effect of the Direct Renin Inhibitor Aliskiren on Urinary Albumin Excretion in Spontaneous Type 2 Diabetic KK-A (y) Mouse
por: Furukawa, Masako, et al.
Publicado: (2013)

Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis
por: Kanaguchi, Yasuhiko, et al.
Publicado: (2011)

Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2014)

Pathological Scenario with the Mannose-Binding Lectin in Patients with IgA Nephropathy
por: Ohsawa, Isao, et al.
Publicado: (2012)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

The Relationship between the Efficacy of Tonsillectomy and Renal Pathology in the Patients with IgA Nephropathy
por: Nomura, Tsutomu, et al.
Publicado: (2014)

Efficacy and indications of tonsillectomy in patients with IgA nephropathy: a retrospective study
por: Li, Yan, et al.
Publicado: (2022)

A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
por: Yanagawa, Hiroyuki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0p1sml1e3gb6dpabb4pmcibvjr